Literature DB >> 24229009

New criteria to predict tumor recurrence in invasive ductal carcinoma of the breast.

Tadahiro Nozoe1, Emiko Mori, Tomohiro Iguchi, Takahiro Ezaki.   

Abstract

Incidence of triple-negative breast cancer (TNBC), which is cancer without expression of ER, PgR, and HER2, and nuclear grade (NG) are closely correlated with malignant potential of breast cancer. However, criteria to determine aggressiveness of breast cancer based on these factors have not been elucidated. The aim of this study was to create criteria using these factors to predict tumor recurrence in invasive ductal carcinoma (IDC) of the breast. One hundred and seventy-nine patients with IDC of the breast, which had been treated by surgical resection, were included. One point was added for each factor of the two categories of TNBC and NG 3. The sum of the scores (TGS 0, 1, or 2) was calculated. Significant difference was observed between TGS and the incidence of tumor recurrence (P < 0.0001). Moreover, significant differences were observed regarding relapse-free survival (RFS) between patients with TGS 0 and TGS 1 (P < 0.0001) and patients with TGS 1 and TGS 2 (P = 0.024). TGS might contain a clinical advantage as a useful predictor for tumor recurrence of IDC of the breast and could classify prognosis of the patients with a preferable stratification.

Entities:  

Mesh:

Year:  2013        PMID: 24229009      PMCID: PMC3829049          DOI: 10.9738/INTSURG-D-12-00029.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  16 in total

1.  Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?

Authors:  Catherine C Parker; Fred Ampil; Gary Burton; Benjamin D L Li; Quyen D Chu
Journal:  Surgery       Date:  2010-07-01       Impact factor: 3.982

2.  Triple-negative breast cancer: clinical features and patterns of recurrence.

Authors:  Rebecca Dent; Maureen Trudeau; Kathleen I Pritchard; Wedad M Hanna; Harriet K Kahn; Carol A Sawka; Lavina A Lickley; Ellen Rawlinson; Ping Sun; Steven A Narod
Journal:  Clin Cancer Res       Date:  2007-08-01       Impact factor: 12.531

3.  Which is the better pathological prognostic factor, the Nottingham histological grade or the Japanese nuclear grade? A large scale study with a long-term follow-up.

Authors:  Yoshiro Otsuki; Shin-ichi Shimizu; Kaori Suwa; Masayuki Yoshida; Masao Kanzaki; Hiroshi Kobayashi
Journal:  Jpn J Clin Oncol       Date:  2007-04       Impact factor: 3.019

4.  Monitoring of interobserver agreement in nuclear atypia scoring of node-negative breast carcinomas judged at individual collaborating hospitals in the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.

Authors:  H Tsuda; F Akiyama; M Kurosumi; G Sakamoto; T Watanabe
Journal:  Jpn J Clin Oncol       Date:  1999-09       Impact factor: 3.019

5.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

6.  Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.

Authors:  H Tsuda; F Akiyama; M Kurosumi; G Sakamoto; T Watanabe
Journal:  Jpn J Clin Oncol       Date:  1998-08       Impact factor: 3.019

7.  Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy.

Authors:  Tomo Osako; Rie Horii; Masaaki Matsuura; Akiko Ogiya; Kaoru Domoto; Yumi Miyagi; Shunji Takahashi; Yoshinori Ito; Takuji Iwase; Futoshi Akiyama
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-14       Impact factor: 4.553

8.  Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation.

Authors:  Gary M Freedman; Penny R Anderson; Tianyu Li; Nicos Nicolaou
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

Review 9.  Cancer survivors in the United States: a review of the literature and a call to action.

Authors:  Manuel Valdivieso; Ann M Kujawa; Tisha Jones; Laurence H Baker
Journal:  Int J Med Sci       Date:  2012-01-17       Impact factor: 3.738

10.  Histological grade and other prognostic factors in relation to survival of patients with breast cancer.

Authors:  L S Freedman; D N Edwards; E M McConnell; D Y Downham
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.